Gene-Chemical Interaction Annotations Click to see Annotation Detail View
Term | Qualifier | Evidence | With | Reference | Notes | Source | Original Reference(s) | 1,2-dichloroethane | increases expression | ISO | Sh3bgr (Mus musculus) | 6480464 | ethylene dichloride results in increased expression of SH3BGR mRNA | CTD | PMID:28960355 | 1,2-dimethylhydrazine | increases expression | ISO | Sh3bgr (Mus musculus) | 6480464 | 1 and 2-Dimethylhydrazine results in increased expression of SH3BGR mRNA | CTD | PMID:22206623 | 1-naphthyl isothiocyanate | increases expression | EXP | | 6480464 | 1-Naphthylisothiocyanate results in increased expression of SH3BGR mRNA | CTD | PMID:30723492 | 17beta-estradiol | affects expression | ISO | SH3BGR (Homo sapiens) | 6480464 | Estradiol affects the expression of SH3BGR mRNA | CTD | PMID:14699072 | 17beta-estradiol | multiple interactions | ISO | Sh3bgr (Mus musculus) | 6480464 | [Polyphenols co-treated with Estradiol] results in increased expression of SH3BGR mRNA | CTD | PMID:30077407 | 2,3,7,8-tetrachlorodibenzodioxine | increases expression | EXP | | 6480464 | Tetrachlorodibenzodioxin results in increased expression of SH3BGR mRNA | CTD | PMID:32109520 and PMID:33387578 | 3,3',5,5'-tetrabromobisphenol A | increases expression | EXP | | 6480464 | tetrabromobisphenol A results in increased expression of SH3BGR mRNA | CTD | PMID:28300664 | 4,4'-sulfonyldiphenol | increases expression | ISO | Sh3bgr (Mus musculus) | 6480464 | bisphenol S results in increased expression of SH3BGR mRNA | CTD | PMID:30951980 | 4-hydroxyphenyl retinamide | increases expression | ISO | Sh3bgr (Mus musculus) | 6480464 | Fenretinide results in increased expression of SH3BGR mRNA | CTD | PMID:28973697 | 6-propyl-2-thiouracil | decreases expression | EXP | | 6480464 | Propylthiouracil results in decreased expression of SH3BGR mRNA | CTD | PMID:24780913 | acrylamide | decreases expression | EXP | | 6480464 | Acrylamide results in decreased expression of SH3BGR mRNA | CTD | PMID:28959563 | acrylamide | increases expression | ISO | SH3BGR (Homo sapiens) | 6480464 | Acrylamide results in increased expression of SH3BGR mRNA | CTD | PMID:32763439 | aflatoxin B1 | decreases expression | ISO | SH3BGR (Homo sapiens) | 6480464 | Aflatoxin B1 results in decreased expression of SH3BGR mRNA | CTD | PMID:22100608 | aflatoxin B1 | decreases methylation | ISO | SH3BGR (Homo sapiens) | 6480464 | Aflatoxin B1 results in decreased methylation of SH3BGR intron | CTD | PMID:30157460 | aldehydo-D-glucose | decreases expression | ISO | Sh3bgr (Mus musculus) | 6480464 | Glucose results in decreased expression of SH3BGR mRNA | CTD | PMID:31525975 | all-trans-retinoic acid | multiple interactions | ISO | Sh3bgr (Mus musculus) | 6480464 | [mono-(2-ethylhexyl)phthalate co-treated with Tretinoin] results in decreased expression of SH3BGR mRNA | CTD | PMID:36189433 | all-trans-retinoic acid | decreases expression | ISO | Sh3bgr (Mus musculus) | 6480464 | Tretinoin results in decreased expression of SH3BGR mRNA | CTD | PMID:36189433 | alpha-Zearalanol | decreases expression | EXP | | 6480464 | Zeranol results in decreased expression of SH3BGR mRNA | CTD | PMID:35163327 | alpha-Zearalanol | multiple interactions | EXP | | 6480464 | [Zeranol co-treated with perfluorooctanoic acid] results in decreased expression of SH3BGR mRNA | CTD | PMID:35163327 | avobenzone | decreases expression | ISO | SH3BGR (Homo sapiens) | 6480464 | avobenzone results in decreased expression of SH3BGR mRNA | CTD | PMID:31016361 | benzo[a]pyrene | decreases methylation | ISO | SH3BGR (Homo sapiens) | 6480464 | Benzo(a)pyrene results in decreased methylation of SH3BGR 5' UTR | CTD | PMID:27901495 | benzo[a]pyrene | affects methylation | ISO | SH3BGR (Homo sapiens) | 6480464 | Benzo(a)pyrene affects the methylation of SH3BGR intron | CTD | PMID:30157460 | bisphenol A | increases expression | ISO | Sh3bgr (Mus musculus) | 6480464 | bisphenol A results in increased expression of SH3BGR mRNA | CTD | PMID:29161229 | bisphenol A | decreases expression | EXP | | 6480464 | bisphenol A results in decreased expression of SH3BGR mRNA | CTD | PMID:34947998 | bisphenol A | increases expression | ISO | SH3BGR (Homo sapiens) | 6480464 | bisphenol A results in increased expression of SH3BGR mRNA and bisphenol A results in increased expression of SH3BGR protein | CTD | PMID:37244401 and PMID:37567409 | bisphenol A | increases expression | EXP | | 6480464 | bisphenol A results in increased expression of SH3BGR mRNA | CTD | PMID:32145629 | bisphenol F | increases expression | ISO | Sh3bgr (Mus musculus) | 6480464 | bisphenol F results in increased expression of SH3BGR mRNA | CTD | PMID:30951980 | cadmium dichloride | increases expression | EXP | | 6480464 | Cadmium Chloride results in increased expression of SH3BGR mRNA | CTD | PMID:25993096 | cantharidin | decreases expression | ISO | Sh3bgr (Mus musculus) | 6480464 | Cantharidin results in decreased expression of SH3BGR mRNA | CTD | PMID:36907384 | carbamazepine | affects expression | ISO | SH3BGR (Homo sapiens) | 6480464 | Carbamazepine affects the expression of SH3BGR mRNA | CTD | PMID:25979313 | carbon nanotube | decreases expression | ISO | Sh3bgr (Mus musculus) | 6480464 | Nanotubes more ... | CTD | PMID:25554681 | chlordecone | increases expression | ISO | Sh3bgr (Mus musculus) | 6480464 | Chlordecone results in increased expression of SH3BGR mRNA | CTD | PMID:33711761 | chrysene | increases expression | ISO | Sh3bgr (Mus musculus) | 6480464 | chrysene results in increased expression of SH3BGR mRNA | CTD | PMID:26377693 | cisplatin | decreases expression | EXP | | 6480464 | Cisplatin results in decreased expression of SH3BGR mRNA | CTD | PMID:22023808 | cobalt dichloride | decreases expression | EXP | | 6480464 | cobaltous chloride results in decreased expression of SH3BGR mRNA | CTD | PMID:24386269 | copper atom | multiple interactions | ISO | SH3BGR (Homo sapiens) | 6480464 | [NSC 689534 binds to Copper] which results in increased expression of SH3BGR mRNA | CTD | PMID:20971185 | copper(0) | multiple interactions | ISO | SH3BGR (Homo sapiens) | 6480464 | [NSC 689534 binds to Copper] which results in increased expression of SH3BGR mRNA | CTD | PMID:20971185 | cyclosporin A | decreases expression | ISO | SH3BGR (Homo sapiens) | 6480464 | Cyclosporine results in decreased expression of SH3BGR mRNA | CTD | PMID:20106945 | cyclosporin A | increases expression | ISO | SH3BGR (Homo sapiens) | 6480464 | Cyclosporine results in increased expression of SH3BGR mRNA | CTD | PMID:27989131 | D-glucose | decreases expression | ISO | Sh3bgr (Mus musculus) | 6480464 | Glucose results in decreased expression of SH3BGR mRNA | CTD | PMID:31525975 | dibutyl phthalate | increases expression | ISO | Sh3bgr (Mus musculus) | 6480464 | Dibutyl Phthalate results in increased expression of SH3BGR mRNA | CTD | PMID:21266533 | dibutyl phthalate | increases expression | EXP | | 6480464 | Dibutyl Phthalate results in increased expression of SH3BGR mRNA | CTD | PMID:21266533 | diuron | increases expression | EXP | | 6480464 | Diuron results in increased expression of SH3BGR mRNA | CTD | PMID:21551480 | dorsomorphin | multiple interactions | ISO | SH3BGR (Homo sapiens) | 6480464 | [NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1 and 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of SH3BGR mRNA | CTD | PMID:27188386 | doxorubicin | decreases expression | ISO | SH3BGR (Homo sapiens) | 6480464 | Doxorubicin results in decreased expression of SH3BGR mRNA | CTD | PMID:29803840 and PMID:30031762 | endosulfan | decreases expression | EXP | | 6480464 | Endosulfan results in decreased expression of SH3BGR mRNA | CTD | PMID:29391264 | entinostat | increases expression | ISO | SH3BGR (Homo sapiens) | 6480464 | entinostat results in increased expression of SH3BGR mRNA | CTD | PMID:27188386 | ethyl methanesulfonate | increases expression | ISO | SH3BGR (Homo sapiens) | 6480464 | Ethyl Methanesulfonate results in increased expression of SH3BGR mRNA | CTD | PMID:23649840 | gentamycin | increases expression | EXP | | 6480464 | Gentamicins results in increased expression of SH3BGR mRNA | CTD | PMID:33387578 | glucose | decreases expression | ISO | Sh3bgr (Mus musculus) | 6480464 | Glucose results in decreased expression of SH3BGR mRNA | CTD | PMID:31525975 | hydroquinone | increases expression | ISO | SH3BGR (Homo sapiens) | 6480464 | hydroquinone results in increased expression of SH3BGR mRNA | CTD | PMID:31256213 | lead(0) | affects expression | ISO | SH3BGR (Homo sapiens) | 6480464 | Lead affects the expression of SH3BGR mRNA | CTD | PMID:28903495 | methoxychlor | affects methylation | EXP | | 6480464 | Methoxychlor affects the methylation of SH3BGR gene | CTD | PMID:35440735 | methyl methanesulfonate | increases expression | ISO | SH3BGR (Homo sapiens) | 6480464 | Methyl Methanesulfonate results in increased expression of SH3BGR mRNA | CTD | PMID:23649840 | methylseleninic acid | increases expression | ISO | SH3BGR (Homo sapiens) | 6480464 | methylselenic acid results in increased expression of SH3BGR mRNA | CTD | PMID:18548127 | mono(2-ethylhexyl) phthalate | decreases expression | ISO | Sh3bgr (Mus musculus) | 6480464 | mono-(2-ethylhexyl)phthalate results in decreased expression of SH3BGR mRNA | CTD | PMID:22401849 | mono(2-ethylhexyl) phthalate | multiple interactions | ISO | Sh3bgr (Mus musculus) | 6480464 | [mono-(2-ethylhexyl)phthalate co-treated with Tretinoin] results in decreased expression of SH3BGR mRNA | CTD | PMID:36189433 | nickel atom | decreases expression | ISO | SH3BGR (Homo sapiens) | 6480464 | Nickel results in decreased expression of SH3BGR mRNA | CTD | PMID:24768652 and PMID:25583101 | octadecanoic acid | increases expression | ISO | SH3BGR (Homo sapiens) | 6480464 | stearic acid results in increased expression of SH3BGR mRNA | CTD | PMID:32347412 | ozone | increases phosphorylation | EXP | | 6480464 | Ozone results in increased phosphorylation of SH3BGR protein | CTD | PMID:33146391 | perfluorooctane-1-sulfonic acid | increases expression | EXP | | 6480464 | perfluorooctane sulfonic acid results in increased expression of SH3BGR mRNA | CTD | PMID:22237054 | perfluorooctanoic acid | multiple interactions | EXP | | 6480464 | [Zeranol co-treated with perfluorooctanoic acid] results in decreased expression of SH3BGR mRNA | CTD | PMID:35163327 | pirinixic acid | multiple interactions | ISO | Sh3bgr (Mus musculus) | 6480464 | [pirinixic acid binds to and results in increased activity of PPARA protein] which results in decreased expression of SH3BGR mRNA | CTD | PMID:19710929 | quercetin | increases expression | ISO | SH3BGR (Homo sapiens) | 6480464 | Quercetin results in increased expression of SH3BGR mRNA | CTD | PMID:21632981 | rotenone | decreases expression | EXP | | 6480464 | Rotenone results in decreased expression of SH3BGR mRNA | CTD | PMID:28374803 | SB 431542 | multiple interactions | ISO | SH3BGR (Homo sapiens) | 6480464 | [NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1 and 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of SH3BGR mRNA | CTD | PMID:27188386 | sunitinib | decreases expression | ISO | SH3BGR (Homo sapiens) | 6480464 | Sunitinib results in decreased expression of SH3BGR mRNA | CTD | PMID:31533062 | Tetrachlorobisphenol A | decreases expression | ISO | SH3BGR (Homo sapiens) | 6480464 | tetrachlorodian results in decreased expression of SH3BGR mRNA | CTD | PMID:31326446 | thalidomide | decreases expression | ISO | Sh3bgr (Mus musculus) | 6480464 | Thalidomide results in decreased expression of SH3BGR mRNA | CTD | PMID:26217789 | titanium dioxide | decreases expression | ISO | Sh3bgr (Mus musculus) | 6480464 | titanium dioxide results in decreased expression of SH3BGR mRNA | CTD | PMID:23557971 | toluene | decreases expression | EXP | | 6480464 | Toluene results in decreased expression of SH3BGR mRNA | CTD | PMID:22967744 | triclosan | decreases expression | ISO | SH3BGR (Homo sapiens) | 6480464 | Triclosan results in decreased expression of SH3BGR mRNA | CTD | PMID:30510588 | tunicamycin | increases expression | ISO | SH3BGR (Homo sapiens) | 6480464 | Tunicamycin results in increased expression of SH3BGR mRNA | CTD | PMID:29453283 | valproic acid | affects expression | ISO | Sh3bgr (Mus musculus) | 6480464 | Valproic Acid affects the expression of SH3BGR mRNA | CTD | PMID:17963808 | valproic acid | affects expression | ISO | SH3BGR (Homo sapiens) | 6480464 | Valproic Acid affects the expression of SH3BGR mRNA | CTD | PMID:25979313 | valproic acid | multiple interactions | ISO | SH3BGR (Homo sapiens) | 6480464 | [NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1 and 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of SH3BGR mRNA | CTD | PMID:27188386 | valproic acid | increases expression | ISO | SH3BGR (Homo sapiens) | 6480464 | Valproic Acid results in increased expression of SH3BGR mRNA | CTD | PMID:23179753 more ... | vorinostat | increases expression | ISO | SH3BGR (Homo sapiens) | 6480464 | vorinostat results in increased expression of SH3BGR mRNA | CTD | PMID:27188386 | |